Ocasio, J., Meidinger, J., & Gershon, T. (2017). MEDU-31. GSK-3 PROMOTES PROLIFERATION DURING POSTNATAL CEREBELLAR DEVELOPMENT AND MAY BE TARGETED IN MEDULLOBLASTOMA THERAPY. Neuro Oncol.
Styl cytowania ChicagoOcasio, Jennifer, Jessica Meidinger, i Timothy Gershon. "MEDU-31. GSK-3 PROMOTES PROLIFERATION DURING POSTNATAL CEREBELLAR DEVELOPMENT AND MAY BE TARGETED IN MEDULLOBLASTOMA THERAPY." Neuro Oncol 2017.
Styl cytowania MLAOcasio, Jennifer, Jessica Meidinger, i Timothy Gershon. "MEDU-31. GSK-3 PROMOTES PROLIFERATION DURING POSTNATAL CEREBELLAR DEVELOPMENT AND MAY BE TARGETED IN MEDULLOBLASTOMA THERAPY." Neuro Oncol 2017.
Uwaga: Te cytaty mogą odróżniać się od wytycznej twojego fakultetu..